UC Davis | Strategic Alliance Partners

Latest from UC Davis


Risk-Based Triaged Mammograms Demonstrate Success During Periods of Reduced Capacity

April 28, 2021

Triaging individuals with the highest likelihood of cancer detection with their clinical indication and individual risk factors during periods of reduced capacity could be an efficient way of identifying the most cancers with the least examinations compared with a non–risk-based approach.

NCCN Announces UC Davis Comprehensive Cancer Center as 31st Member Institution

April 16, 2021

Experts from Northern California-based cancer center to join panels responsible for evidence- based recommendations in NCCN Clinical Practice Guidelines and NCCN Guidelines for Patients, among other resources to improve outcomes for people with cancer.

Frontline mRCC Paradigm Crowds Among Immune-Based Treatment Options

March 13, 2021

The emergence of multiple combination regimens with immunotherapy and TKIs has been welcome for the frontline treatment of patients with metastatic renal cell carcinoma; however, without head-to-head comparative data, treatment selection has become individualized based on available patient characteristics.